USA: A multinational clinical trial published in the New England Journal of Medicine has reported that ultrasound ...

A PET radiotracer that can visualize deep vein thrombosis and pulmonary embolism wins the Society of Nuclear Medicine and ...

PET/CT Awarded SNMMI’s Image of the Year (Left) 18F-GP1 PET/CT images from a 75-year-old woman show multiple blood clots in ...

Los Angeles -- A novel PET radiotracer can accurately detect deep vein thrombosis in the legs and reveal whether clots have migrated to the lungs. By enabling whole‑body imaging of blood clots in a ...

More news: Shares in 4DMedical tumbled in afternoon trade despite the medical imaging company unveiling a new clinical ...

Medical Ltd (ASX: 4DX) shares were higher on Tuesday after the company said it was targeting the large pulmonary embolism ...

A novel PET radiotracer can accurately detect deep vein thrombosis in the legs and reveal whether clots have migrated to the ...

A novel PET radiotracer can accurately detect deep vein thrombosis in the legs and reveal whether clots have migrated to the lungs. By enabling whole‑body imaging of blood clots in a single scan, the ...

Researchers assessed the relationship between pre-existing PH and inpatient outcomes in adults hospitalized with acute pulmonary embolism.

The risk of clinically relevant bleeding was significantly lower with apixaban compared with rivaroxaban among patients with acute venous thromboembolism (VTE) during a three-month treatment period, ...

The “open vein hypothesis” postulates that early thrombus clearance and restoration of venous blood flow may prevent postthrombotic syndrome after proximal deep vein thrombosis. Since its proposal ...

Patients treated with apixaban (Eliquis; Bristol Myers Squibb) for 3 months after acute venous thromboembolism (VTE) report more than half the rate of clinically relevant bleeding compared with those ...